Shareholder update
Aberdeen Global Fund and Standard Life Investments Global SICAV Fund are Luxembourg-based SICAV fund ranges that consist of a number of sub-funds, which are authorised for sale in Hong Kong. Please see below shareholder updates and subscription information of both fund ranges.
Shareholder Updates
8 May 2019
Shareholder notice on changes to Aberdeen Standard SICAV I and its sub-funds
Details1 Apr 2019
Shareholder Notice on Aberdeen Standard SICAV I – Latin American Equity Fund
Details21 December 2018
Shareholder notice on changes to Aberdeen Global and its sub-funds
Details3 December 2018
Shareholder notice on Aberdeen Global – Emerging Markets Smaller Companies Fund, a sub-fund of Aberdeen Global
Details26 October 2018
Changes on Aberdeen Global and its sub-funds
Details3 August 2018
Information for Investors in Aberdeen Global – Chinese Equity Fund: Erratum to notice dated 15 June 2018
Details15 June 2018
Changes in Aberdeen Global - Decrease in the sales charges, changes in the Aberdeen Global – Asian Local Currency Short Duration Bond Fund and Aberdeen Global – Chinese Equity Fund, with effect from 16 July 2018
Details27 April 2018
Changes to the format of Hong Kong Offering Documents, with effect from 30 April 2018
Details16 April 2018
Further Notice to Shareholders of Aberdeen Global – Indian Equity Fund
Details29 March 2018
Changes to the Aberdeen Global and existing funds, including name change of Aberdeen International Fund Managers Limited
Details26 January 2018
Change of Address of Aberdeen International Fund Managers Limited
Details3 January 2018
Notice to Shareholders of Aberdeen Global – Indian Equity Fund
DetailsAberdeen Global Fund - Subscription information and charges
To invest in Aberdeen Global, please read the offering documents and the product key facts statements below.
Details of the fees and expenses relating to Aberdeen Global are set out in the section headed “Charges and Expenses” of the Prospectus. Investor should refer to the fund offering documents for further details.